6 Recruiting Urothelial Carcinoma Phase 1 Clinical Trials
Active phase 1 studies for urothelial carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Urothelial Carcinoma studiesPhase 1 Studies for Urothelial Carcinoma
🔵 Active, Not Recruiting Phase1
Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
📍 Stephenson Cancer Center — Oklahoma City, Oklahoma
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
📍 Exelixis Clinical Site #53 — Gilbert, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
📍 Rocky Mountain Cancer Centers — Aurora, Colorado
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
📍 BCG Oncology — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
📍 University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045) — Orange, California
View Study & Checklist ➔